CEO · Founder, Ellume Health
Stories naming Dr Sean Parsons. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Ellume's Australian operations have entered voluntary administration, with FTI Consulting appointed administrators; the US business continues. The Brisbane diagnostics maker earlier raised $5 million and won a big US government supply contract.
Also Startup Daily
Brisbane diagnostics company Ellume signed a US government contract worth US$231.8 million to supply Covid-19 home tests and build a US factory, alongside earlier grants from the NIH and Queensland government.
Also SmartCompany·SmartCompany·Startup Daily·@AuManufacturing
Brisbane diagnostics company Ellume wins US emergency authorisation for its COVID-19 home test, backed by an earlier NIH grant and a mid-2020 private raise as it scales production.
Also Startup Daily
Brisbane diagnostics maker Ellume is scaling up COVID-19 test production with Queensland Government backing through its supply chain programme, while Bosch's manufacturing arm automates the high-volume lines.
Roundup of Australian manufacturing briefs: Bosch's automation arm partners with Ellume on COVID-19 test production, Tonga receives an Austal-built patrol boat, Micro-X ships Rover X-ray units, and Envirostream wins a government recycling grant.
Brisbane diagnostics company Ellume has raised $5 million to commercialise its products and prepare for a future ASX listing, though its investors remain undisclosed.
Profile of Ellume, a Queensland diagnostics startup whose founder Dr Sean Parsons describes smartphone flu self-testing, partnerships with GSK and QIAGEN, and a planned ASX float within a year.